Regulation of growth-related genes by interleukin-6 in murine myeloma cells

Cytokine

Volumn 20, Issue 3, 2002, Pages 113-120

  Côté, Serge ^a,b   Simard, Carl ^a   Lemieux, Réal ^a  

^a HÉMA QUÉBEC   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

Cell proliferation; Differential gene expression; IL 6; Myeloma; TOPK PBK

Indexed keywords

COMPLEMENTARY DNA; ENZYME; INTERLEUKIN 6; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PROTEIN; GROWTH PROMOTOR; RECOMBINANT PROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DIVISION; CELL LINE; CONTROLLED STUDY; GENE; GENE CONTROL; GENE EXPRESSION; HYBRIDIZATION; IN VITRO STUDY; MYELOMA CELL; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; TUMOR GROWTH; UPREGULATION; ANIMAL; CELL CULTURE; CELL CYCLE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MOLECULAR GENETICS; MOUSE; MULTIPLE MYELOMA; NUCLEOTIDE SEQUENCE; PATHOLOGY;

MURINAE;

ANIMALS; BASE SEQUENCE; CELL CYCLE; GENE EXPRESSION REGULATION, NEOPLASTIC; GROWTH SUBSTANCES; HUMANS; INTERLEUKIN-6; MICE; MOLECULAR SEQUENCE DATA; MULTIPLE MYELOMA; RECOMBINANT PROTEINS; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0036435118     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.2002.1988     Document Type: Article

References (48)

1. Hirano T (1998) Interleukin 6 and its receptor: Ten years later. Intern Rev Immunol 16:249-284.
2. Taga T, Kishimoto T (1997) Gp130 and the interleukin-6 family of cytokines. Annu Rev Immunol 15:797-819.
3. Kishimoto T, Akira S, Taga T (1994) Cytokine signal transduction. Cell 76:253-262.
4. Fukada T, Hibi M, Yamanaka Y, Takahashi-Tezuka M, Fujitani Y, Yamaguchi T, Nakajima K, Hirano T (1996) Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: Involvement of STAT3 in anti-apoptosis. Immunity 5:449-460.
5. Ogata A, Chauhan D, Teoh G, Treon SP, Urashima M, Schlossman RL, Anderson KC (1997) IL-6 triggers cell growth via the ras-dependent mitogen-activated protein kinase cascade. J Immunol 159:2212-2221.
6. Reuther GW, Der CJ (2000) The Ras branch of small GTPases: Ras family members don't fall far from tree. Curr Opin Cell Biol 12:157-165.
7. Garrington TP, Johnson GL (1999) Organization and regulation of mitogen-activated protein kinase signaling pathways. Curr Opin Cell Biol 11:211-218.
8. Klein B, Zhang X-G, Lu Z-Y, Bataille R (1995) Interleukin-6 in human multiple myeloma. Blood 85:863-872.
9. Hirano T, Suematsu S, Matsusaka T, Matsuda T, Kishimoto T (1992) The role of interleukin 6 in plasmacytomagenesis. Ciba Found Symp 67:188-196; discussion 196-200.
10. Schwarze MM, Hawley RG (1995) Prevention of myeloma cell apoptosis by ectopic bcl-2 expression or interleukin 6-mediated up-regulation of bcl-xL. Cancer Res 55:2262-2265.
11. Rahman Z, Yoshikawa H, Nakajima Y, Tasaka K (2001) Down-regulation of Pim-1 and Bcl-2 is accompanied with apoptosis of interleukin-6-depleted mouse B-cell hybridoma 7TD1 cells. Immun Lett 75:199-208.
12. Xu FH, Sharma S, Gardner A, Tu Y, Raitano A, Sawyers C, Lichtenstein A (1998) Interleukin-6-induced inhibition of multiple myeloma cell apoptosis: Support for the hypothesis that protection is mediated via inhibition of the JNK/SAPK pathway. Blood 92:241-251.
13. Wen XY, Stewart AK, Sooknanan RR, Henderson G, Hawley TS, Reimold AM, Glimcher LH, Baumann H, Malek LT, Hawley RG (1999) Identification of c-myc promoter-binding protein and X-box binding protein 1 as interleukin-6 target genes in human multiple myeloma cells. Int J Oncol 15:173-178.
14. Reimold AM, Iwakoshi NN, Manis J, Vallabhajosyula P, Szomolanyl-Tsuda E, Gravallese EM, Friend D, Grusby MJ, Alt F, Gilmcher LH (2001) Plasma cell differentiation requires the transcription factor XBP-1. Nature 412:300-307.
15. Bazin R, Lemieux R (1987) Role of the macrophage-derived hybridoma growth factor in the in vitro and in vivo proliferation of newly formed B cell hybridomas. J Immunol 139:780-787.
16. Diatchenko L, Lau YF, Campbell AP, Chenchik A, Moqadam F, Huang B, Lukyanov S, Lukyanov K, Gurskaya N, Sverdlov ED, Siebert PD (1996) Suppression subtractive hybridization: A method for generating differentially regulated or tissue-specific cDNA probes and libraries. Proc Natl Acad Sci USA 93:6025-6030.
17. Tchernitsa OI, Zuber J, Sers C, Brinckmann R, Britsch SK, Adams V, Schafer R (1999) Gene expression profiling of fibroblasts resistant toward oncogene-mediated transformation reveals preferential transcription of negative growth regulators. Oncogene 18:5448-5454.
18. Kostic C, Shaw PH (2000) Isolation and characterization of sixteen novel p53 response genes. Oncogene 19:3978-3987.
19. Buchaille R, Couble ML, Magloire H, Bleicher F (2000) A substractive PCR-based cDNA library from human odontoblast cells: Identification of novel genes expressed in tooth forming cells. Matrix Biol 19:421-430.
20. Bertram J, Palfner K, Hiddemann W, Kneba M (1998) Elevated expression of S100P CAPL and MAGE 3 in doxorubicin-resistant cell lines: Comparison of mRNA differential display reverse transcription-polymerase chain reaction and subtractive suppressive hybridization for the analysis of differential gene expression. Anticancer Drugs 9:311-317.
21. Harris AJ, Shaddock JG, Manjanatha MG, Lisenbey JA, Casciano DA (1998) Identification of differentially expressed genes in aflatoxin B1-treated cultured primary rat hepatocytes and Fischer 344 rats. Carcinogenesis 19:1451-1458.
22. Ye Z, Connor JR (2000) Identification of iron responsive genes by screening cDNA libraries from suppression subtractive hybridization with antisense probes from three iron conditions. Nucleic Acids Res 28:1802-1807.
23. Krude T (1999) Mimosine arrests proliferating human cells before onset of DNA replication in a dose-depenedent manner. Exp Cell Res 247:148-159.
24. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular Cloning: A Laboratory Manual. CSH Laboratory Press Cold Spring Harbor, New York.
25. Engler-Blum G, Meier M, Frank J, Muller GA (1993) Reduction of background problems in nonradioactive northern and Southern blot analyses enables higher sensitivity than 32P-based hybridizations. Anal Biochem 210:235-244.
26. Simard C, Lemieux R, Coêté S (2001) Urea substitutes toxic formamide as destabilizing agent in nucleic acid hybridization with RNA probes. Electrophoresis 22:2679-2683.
27. Pagano M, Pepperkok R, Verde F, Ansorge W, Draetta G (1992) Cyclin A is required at two points in the human cell cycle. EMBO J 11:961-971.
28. Manser E, Loo TH, Koh CG, Zhao ZS, Chen XQ, Tan L, Tan I, Leung T, Lim L (1998) PAK kinases are directly coupled to the PIX family of nucleotide exchange factors. Mol Cell 1:183-192.
29. Kersher SJ (2000) Diversity and origin of alternative NADH: Ubiquinone oxydoreductases. Biochim Biophys Acta 1459:274-283.
30. Chiba H, Muramatsu M, Nomoto A, Kato H (1994) Two human homologues of Saccharomyces cerevisiae SWI2/SNF2 and Drosophila brahma are transcriptional coactivators cooperating with the estrogen receptor and the retinoic acid receptor. Nucleic Acids Res 22:1815-1820.
31. Dunaief JL, Strober BE, Guha S, Khavari PA, Alin K, Luban J, Begemann M, Crabtree GR, Goff SP (1994) The retino-blastoma protein and BRG1 form a complex and cooperate to induce cell cycle arrest. Cell 79:119-130.
32. Modaressi S, Brechtel K, Christ B, Jungermann K (1998) Human mitochondrial phosphoenolpyruvate carboxykinase 2 gene Structure chromosomal localization and tissue-specific expression. Biochem J 333(Pt 2):359-366.
33. Mecham RP, Davis EC (1994) Elastic fiber structure and assembly. In Yurchenko PD, Birk DE, Mecham RP (eds) Extracellular Matrix Assembly and Structure. Academic Press, San Diego, pp 281-314.
34. Murakami Y, Ichiba T, Matsufuji S, Hayashi S (1996) Cloning of antizyme inhibitor a highly homologous protein to ornithine decarboxylase. J Biol Chem 271:3340-3342.
35. Koguchi K, Kobayashi S, Hayashi T, Matsufuji S, Murakami Y, Hayashi S (1997) Cloning and sequencing of a human cDNA encoding ornithine decarboxylase antizyme inhibitor. Biochim Biophys Acta 1353:209-216.
36. Nilsson J, Grahn B, Heby O (2000) Antizyme inhibitor is rapidly induced in growth-stimulated mouse fibroblasts and releases ornithine decarboxylase from antizyme suppression. Biochem J 346:699-704.
37. Abe Y, Matsumoto S, Kito K, Ueda N (2000) Cloning and expression of a novel MAPKK-like protein kinase lymphokine-activated killer T-cell-originated protein kinase specifically expressed in the testis and activated lymphoid cells. J Biol Chem 275:21525-21531.
38. Gaudet S, Branton D, Lue RA (2000) Characterization of PDZ-binding kinase a mitotic kinase. Proc Natl Acad Sci USA 97:5167-5172.
39. Peterszegi G, Robert L (1998) Cell death induced in lymphocytes expressing the elastin-laminin receptor by excess agonists: Necrosis and apoptosis. Biomed Pharmacother 52:369-377.
40. Kroemer G, Reed JC (2000) Mitochondrial control of cell death. Nat Med 6:513-519.
41. Ono K, Han J (2000) The p38 signal transduction pathway: Activation and function. Cell Signal 12:1-13.
42. Salmon RA, Foltz IN, Young PR, Schrader JW (1997) The p38 mitogen-activated protein kinase is activated by ligation of the T or B lymphocyte antigen receptors Fas or CD40 but suppression of kinase activity does not inhibit apoptosis induced by antigen receptors. J Immunol 159:5309-5317.
43. Craxton A, Shu G, Graves JD, Saklatvala J, Krebs EG, Clark EA (1998) P38 MAPK is required for CD40-induced gene expression and proliferation in B lymphocytes. J Immunol 161:3225-3236.
44. Saccani S, Pantano S, Natoli G (2002) p38-dependent marking of inflammatory genes for increased NK-κB recruitment. Nature Immunol 3:69-75.
45. Zhang L, Zhou W, Velculescu VE, Kern SE, Hruban RH, Hamilton SR, Vogelstein B, Kinzler KW (1997) Gene expression profiles in normal and cancer cells. Science 276:1268-1272.
46. Notterman DA, Alon U, Sierk AJ, Levine AJ (2001) Transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma, and normal tissue examined by oligonucleotide arrays. Cancer Res 61:3124-3130.
47. Boon K, Osorio EC, Greenhut SF, Schaefer CF, Shoemaker J, Polyak K, Morin PJ, Buetow KH, Strausberg RL, De Souza SJ, Riggins GJ (2002) An anatomy of normal and malignant gene expression. Proc Natl Acad Sci USA 99:11287-112892.
48. Simons-Evelyn M, Bailey-Dell K, Toretsky JA, Ross DD, Fenton R, Kalvakolanu D, Rapoport AP (2001) PBK/TOPK is a novel mitotic kinase which is upregulated in Burkitt's lymhoma and other highly proliferative malignant cells. Blood Cells Mol Dis 27:825-829.